The growth of the Myotonic Dystrophy Treatment Market is being fueled by strategic initiatives adopted by leading ...

A team of researchers has identified a promising therapy based on antimiRs to treat myotonic dystrophy type 1 (DM1), a ...

A coroner rules that "gross failure" in the hospital care of a disabled woman "possibly contributed to her death".

A team of researchers led by Instituto de Investigación Sanitaria de INCLIVA-Universitat de València, in collaboration with various other research sites, including Germans Trias i Pujol Research ...

Chloe Every had learning difficulties and a muscle-wasting condition and was admitted to Queen’s Hospital in Romford in April ...

SAVANNAH, Georgia — Heart problems are common in the vast majority of neuromuscular disorders, and cardiac monitoring of ...

Ontario Health Minister Sylvia Jones says the government is working with Ontario Health atHome to resolve the “completely ...

The three-horse race to treat a devastating form of muscular dystrophy is now down to two. And Avidity Biosciences is feeling ...

Treatment with an RNA-based therapy approach was found to correct molecular defects in a cell model of myotonic dystrophy ...

Two years after the US agency placed the partial clinical hold, Avidity can resume the research of del-desiran as a treatment ...